 |
PDBsum entry 4ztf
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transferase/DNA/inhibitor
|
PDB id
|
|
|
|
4ztf
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class 2:
|
 |
Chains A, B:
E.C.2.7.7.-
- ?????
|
|
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
Chains A, B:
E.C.2.7.7.49
- RNA-directed Dna polymerase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
DNA(n) + a 2'-deoxyribonucleoside 5'-triphosphate = DNA(n+1) + diphosphate
|
 |
 |
 |
 |
 |
DNA(n)
|
+
|
2'-deoxyribonucleoside 5'-triphosphate
|
=
|
DNA(n+1)
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 4:
|
 |
Chains A, B:
E.C.2.7.7.7
- DNA-directed Dna polymerase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
DNA(n) + a 2'-deoxyribonucleoside 5'-triphosphate = DNA(n+1) + diphosphate
|
 |
 |
 |
 |
 |
DNA(n)
|
+
|
2'-deoxyribonucleoside 5'-triphosphate
|
=
|
DNA(n+1)
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 5:
|
 |
Chains A, B:
E.C.3.1.-.-
|
|
 |
 |
 |
 |
 |
Enzyme class 6:
|
 |
Chains A, B:
E.C.3.1.26.4
- ribonuclease H.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Endonucleolytic cleavage to 5'-phosphomonoester.
|
 |
 |
 |
 |
 |
Enzyme class 7:
|
 |
Chains A, B:
E.C.3.4.23.-
- ?????
|
|
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Med Chem
58:8154-8165
(2015)
|
|
PubMed id:
|
|
|
|
|
| |
|
Discovery of 2-Pyridinone Aminals: A Prodrug Strategy to Advance a Second Generation of HIV-1 Integrase Strand Transfer Inhibitors.
|
|
I.T.Raheem,
A.M.Walji,
D.Klein,
J.M.Sanders,
D.A.Powell,
P.Abeywickrema,
G.Barbe,
A.Bennet,
K.Childers,
M.Christensen,
S.D.Clas,
D.Dubost,
M.Embrey,
J.Grobler,
M.J.Hafey,
T.J.Hartingh,
D.J.Hazuda,
J.T.Kuethe,
J.McCabe Dunn,
M.D.Miller,
K.P.Moore,
A.Nolting,
N.Pajkovic,
S.Patel,
Z.Peng,
V.Rada,
P.Rearden,
J.D.Schreier,
J.Sisko,
T.G.Steele,
J.F.Truchon,
J.Wai,
M.Xu,
P.J.Coleman.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The search for new molecular constructs that resemble the critical two-metal
binding pharmacophore required for HIV integrase strand transfer inhibition
represents a vibrant area of research within drug discovery. Here we present the
discovery of a new class of HIV integrase strand transfer inhibitors based on
the 2-pyridinone core of MK-0536. These efforts led to the identification of two
lead compounds with excellent antiviral activity and preclinical pharmacokinetic
profiles to support a once-daily human dose prediction. Dose escalating PK
studies in dog revealed significant issues with limited oral absorption and
required an innovative prodrug strategy to enhance the high-dose plasma
exposures of the parent molecules.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
|